Status:
RECRUITING
Effect of Pulsatile Hormone Administration on Insulin Action
Lead Sponsor:
Pennington Biomedical Research Center
Conditions:
Insulin Sensitivity
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
In humans, insulin is secreted in pulses from the pancreatic beta-cells, and these oscillations help to maintain fasting plasma glucose levels within a narrow normal range. Given the fluctuations in i...
Detailed Description
Participants with obesity and insulin resistance completing a randomized, controlled, two-arm parallel trial (Motivate) will be enrolled in this cross-sectional study. Twelve participants from the Mot...
Eligibility Criteria
Inclusion
- Completion of the Motivate Study (NCT05649176)
Exclusion
- Non-completion of the end-of-study hyperinsulinemic euglycemic clamp test of the Motivate study
Key Trial Info
Start Date :
March 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06216665
Start Date
March 4 2024
End Date
December 1 2025
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States, 70808